TAOK1 Rabbit Polyclonal Antibody
CAT#: TA386880
TAOK1 Rabbit polyclonal antibody
Size: 50 ul
Need it in bulk or conjugated? 
                            Get a free quote
                        
CNY 1999.00
CNY 3280.00
                                                
                                                
                                                
                                                    CNY 300.00 
                                                    
                                                    CNY 1430.00
                                                
                                            
Specifications
| Product Data | |
| Applications | IF, IHC, WB | 
| Recommend Dilution | Recommended dilution: WB:1:1000-1:5000, IHC:1:200-1:500, IF:1:50-1:200 | 
| Reactivity | Human | 
| Host | Rabbit | 
| Clonality | Polyclonal | 
| Immunogen | Recombinant Human Serine/threonine-protein kinase TAO1 protein (400-659AA) | 
| Isotype | IgG | 
| Formulation | Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, pH 7.4  | 
        
| Concentration | lot specific | 
| Purification | >95%, Protein G purified | 
| Conjugation | Unconjugated | 
| Storage Condition | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. | 
| Database Link | |
| Background | Serine/threonine-protein kinase involved in various processes such as p38/MAPK14 stress-activated MAPK cascade, DNA damage response and regulation of cytoskeleton stability. Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of the p38/MAPK14 stress-activated MAPK cascade by mediating phosphorylation and subsequent activation of the upstream MAP2K3 and MAP2K6 kinases. Involved in G-protein coupled receptor signaling to p38/MAPK14. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of cytoskeleton stability by phosphorylating 'Thr-208' of MARK2, leading to activate MARK2 kinase activity and subsequent phosphorylation and detachment of MAPT/TAU from microtubules. Also acts as a regulator of apoptosis: regulates apoptotic morphological changes, including cell contraction, membrane blebbing and apoptotic bodies formation via activation of the MAPK8/JNK cascade. | 
| Reference Data | |
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
